NANCY CHOKSHI TANEJA
Allopathic & Osteopathic Physicians|Pediatrics PLANO, TX NPI 1821256736
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics TX Welch Allyn All categories
General Payments — all program years on this page
$988.53
- Category: General Payments
- Program years: PY2018–2021
- Record count: 50
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $218.57 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $110.32 | 6 |
| Debt forgiveness | $108.25 | 1 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Welch Allyn | $108.25 | 1 |
| Tris Pharma Inc | $43.58 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.96 | 1 |
| Supernus Pharmaceuticals, Inc. | $15.83 | 1 |
| Merck Sharp & Dohme Corporation | $14.16 | 1 |
| Adlon Therapeutics L.P. | $11.79 | 1 |
By program year
Records — PY2021 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 820296761 | Takeda Pharmaceuticals U.S.A., Inc. | $24.96 | 04/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 844849677 | Adlon Therapeutics L.P. | $11.79 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 845122779 | Supernus Pharmaceuticals, Inc. | $15.83 | 05/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848392127 | Merck Sharp & Dohme Corporation | $14.16 | 05/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 851963711 | Tris Pharma Inc | $19.96 | 03/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 851963755 | Tris Pharma Inc | $23.62 | 04/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 854036659 | Welch Allyn | $108.25 | 03/25/2021 | Debt forgiveness | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.